MedTrace Logo

Efficacy and Safety of Eriobotyra Japonica Lindley Extract on Improvement of Cognitive Function

NCT01734213 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-09-03

No results posted yet for this study

Summary

The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Eriobotyra Japonica Lindley Extract on improvement of Cognitive Function. The investigators measured improvement of Cognitive Function parameters , including K-MMSE, Ability to perform working memory tasks, CNT and BCRS, and monitored their blood pressure.

Conditions

  • Cognitive Function

Interventions

DIETARY_SUPPLEMENT

Eriobotyra Japonica Lindley Extract

Eriobotyra Japonica Lindley Extract (1.5g/day)

DIETARY_SUPPLEMENT

Placebo

Placebo (1.5g/day)

Sponsors & Collaborators

  • Chonbuk National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-10
Primary Completion
2013-10-15
Completion
2013-10-15

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01734213 on ClinicalTrials.gov